Clinical Trial Update: Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain [Phase 4]

View source ↗

Summary

Phase 4 trial of Dexilant (dexlansoprazole) for gastroesophageal reflux disease-related non-cardiac chest pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

Sponsor: University of Iowa | Conditions: Chest Pain, Gastrointestinal Reflux Disease | Phase 4 | Status: WITHDRAWN